Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Rapid Automated Specialty Panels Test for Bacteria

By Labmedica staff writers
Posted on 02 Jan 2008
New instruments offer simultaneous automation of overnight, rapid, and specialty panels that test for both gram-negative and gram-positive bacteria. More...
The instruments are suitable for mid- and high-volume clinical diagnostic microbiology laboratories.

MicroScan technology was introduced as an advanced technology based on the microbiology principles of true minimum inhibitory concentration (MIC) testing. This principle is a very sensitive method to determine bacteria's susceptibility to antibiotics. The new WalkAway plus Systems combine MIC technology with new automated features, including automated maintenance and dial-up system diagnostics capability.

Launched by Siemens Medical Solutions (Deerfield, IL, USA) the new WalkAway plus systems also offer advanced automation features that improve laboratory productivity by decreasing system maintenance activity. The two new instrument models, a 40-panel capacity model for medium-volume laboratories and a 96-panel capacity model for high-volume laboratories, replace the current WalkAway SI 40 and 96 Systems.

Siemens Medical Solutions Diagnostics has nearly 60 MicroScan panels of tests, with up-to-date antibiotics including the overnight, rapid, and specialty panels. The company was the first to offer an automated identification and susceptibility testing system cleared for improved detection of the emerging resistant bacterium vancomycin-resistant Staphylococcus aureus (VRSA).

"We remain committed to addressing the challenges of today's clinical laboratory,” said Jim Reid-Anderson, president and CEO, Siemens Medical Solutions Diagnostics. "This new innovation for the microbiology laboratory allows customers to improve laboratory workflow and productivity while helping them to continue advancing the quality of patient care in their facilities.”

Siemens Medical Solutions provides medical solutions with core competence and innovative strength in diagnostic and therapeutic technologies. With its laboratory diagnostics acquisitions, Siemens Medical Solutions combines lab diagnostics, imaging, therapy, and healthcare information technology solutions, supplemented by consulting and support services.


Related Links:
Siemens Medical Solutions

Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Human Estradiol Assay
Human Estradiol CLIA Kit
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.